Spitalul Clinic Dr. C.I. Parhon Iasi
- Address
- lock Available on a paid plan
Spitalul Clinic Dr. C.I. Parhon Iasi - Renal and Cardiovascular Research
Spitalul Clinic Dr. C.I. Parhon Iasi is a specialized clinical research center with significant expertise in nephrology and cardiovascular medicine. The center conducts advanced clinical trials focusing on progressive kidney disease and associated cardiovascular complications, utilizing innovative therapeutic approaches to address complex renal conditions.
- Chronic kidney disease (CKD) progression and hypertension management studies
- End-stage kidney disease (ESKD) research with novel immunomodulatory therapies
- Cardiovascular outcomes in dialysis-dependent patients
The facility demonstrates particular strength in evaluating combination therapies for chronic kidney disease with comorbid hypertension, as well as investigating anti-inflammatory strategies for atherosclerotic cardiovascular disease in patients requiring maintenance dialysis. Their research portfolio includes dose-finding studies and assessment of estimated glomerular filtration rate (eGFR) changes and cardiovascular biomarkers such as high-sensitivity C-reactive protein (hs-CRP) in vulnerable renal populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1CSL Behring LLC1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Clinic Dr. C.I. Parhon Iasi
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects with End Stage Kidney Disease Undergoing Dialysis | CSL Behring LLC | Phase IV | Recruiting | Jul 2023 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cilastatin | 1 | Unknown | 2024-03-25 | 2024-03-25 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.